Blog
RSS FeedPosted by Michael Wonder on 19 Apr 2017
Cancer patients want New Zealand funded treatment
20 April 2017 - Patients with a little-known cancer want a new treatment funded in this country, so they don't have ...
Posted by Michael Wonder on 19 Apr 2017
Private health insurance attacked for lack of value and transparency by experts
20 April 2017 - Consumers Health Forum publishes views of 20 experts in latest edition of Health Voices as part of ...
Posted by Michael Wonder on 19 Apr 2017
NICE publishes second appraisal consultation document for cabozantinib maleate
19 April 2017 - The Department of Health has asked NICE to produce guidance on the use of cabozantinib in the ...
Posted by Michael Wonder on 19 Apr 2017
PHARMAC reject request to fund women's hygiene products
19 April 2017 - The government's drug-buying agency has rejected a request to fund women's hygiene products. ...
Posted by Michael Wonder on 17 Apr 2017
Patients resort to paying consultants to help navigate Canada’s Byzantine health care system
14 April 2017 - Andrée Colella had been in and out of hospital for months with bladder and bone infections ...
Posted by Michael Wonder on 17 Apr 2017
Expanding CADTH’s drug review processes to include radiopharmaceuticals
17 April 2017 - In collaboration with the participating jurisdictions, CADTH is pleased to announce that it will accept submissions ...
Posted by Michael Wonder on 14 Apr 2017
Pharma giant Aspen accused of withholding drugs to force up prices
14 April 2017 - Staff at one of the world’s leading drug companies discussed destroying supplies of lifesaving cancer medicines ...
Posted by Michael Wonder on 13 Apr 2017
Agenda for 19 April 2017 TC meeting
13 April 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 13 Apr 2017
Clinuvel reaches agreement on German Scenesse pricing through AMNOG Arbitration Board
12 April 2017 - Clinuvel today announced that it had reached agreement with the German National Association of Statutory Health ...
Posted by Michael Wonder on 12 Apr 2017
HAS publishes Transparency Commission opinion for Keytruda
12 April 2017 - The opinion relates the use of pembrolizumab by patients with non-small-cell lung cancer. ...
Posted by Michael Wonder on 12 Apr 2017
Patented Medicine Prices Review Board will hear closing arguments in the matter of the price of Soliris
12 April 2017 - Closing arguments in the matter of the price of the patented medicine Soliris will be heard from ...
Posted by Michael Wonder on 12 Apr 2017
Why drug appraisal methods need to take into account treatments for rare diseases
12 April 2017 - The UK government needs to adapt its drug and technology appraisal methods to prevent patients with rare ...
Posted by Michael Wonder on 12 Apr 2017
NICE publishes draft guidance on the use of Holoclar (ex vivo expanded autologous human corneal epithelial cells containing stem cells)
12 April 2017 - The Department of Health has asked NICE to produce guidance on using ex vivo expanded autologous human ...
Posted by Michael Wonder on 12 Apr 2017
Why aren’t cancer drugs available throughout UK?
12 April 2017 - Whatever Nicola Sturgeon might wish we remain a United Kingdom. ...
Posted by Michael Wonder on 11 Apr 2017
Policies for use of real-world data in health technology assessment: a comparative study of six HTA agencies
11 April 2017 - Health technology assessment agencies worldwide are thus exploring whether real-world data may provide alternative sources of ...